98 related articles for article (PubMed ID: 22609473)
1. Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking.
Younos IH; Dafferner AJ; Gulen D; Britton HC; Talmadge JE
Int Immunopharmacol; 2012 Jul; 13(3):245-56. PubMed ID: 22609473
[TBL] [Abstract][Full Text] [Related]
2. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
4. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
Lee M; Park CS; Lee YR; Im SA; Song S; Lee CK
Arch Pharm Res; 2014; 37(9):1234-40. PubMed ID: 24748512
[TBL] [Abstract][Full Text] [Related]
5. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
Fu Y; Paul RD; Wang Y; Lopez DM
J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells.
Zheng Y; Xu M; Li X; Jia J; Fan K; Lai G
Mol Immunol; 2013 May; 54(1):74-83. PubMed ID: 23220070
[TBL] [Abstract][Full Text] [Related]
8. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
9. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
Ruppert B; Blazar B; Medina D; Heppner G
J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
12. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic cell therapy for a murine mammary carcinoma.
Morecki S; Yacovlev E; Diab A; Slavin S
Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
[TBL] [Abstract][Full Text] [Related]
14. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
[TBL] [Abstract][Full Text] [Related]
15. Sustained exposure to nicotine leads to extramedullary hematopoiesis in the spleen.
Pandit TS; Sikora L; Muralidhar G; Rao SP; Sriramarao P
Stem Cells; 2006 Nov; 24(11):2373-81. PubMed ID: 16825610
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells.
Su X; Zhang L; Ye J; Yang L; Li Y; Wang Y
Biomed Mater Eng; 2015; 25(1 Suppl):167-77. PubMed ID: 25538067
[TBL] [Abstract][Full Text] [Related]
17. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
Korbelik M; Krosl G; Krosl J; Dougherty GJ
Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
Tamai H; Watanabe S; Zheng R; Deguchi K; Cohen PA; Koski GK; Shu S
Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
[TBL] [Abstract][Full Text] [Related]
19. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors.
DuPre' SA; Hunter KW
Exp Mol Pathol; 2007 Feb; 82(1):12-24. PubMed ID: 16919266
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment.
Guo Q; Lv Z; Fu Q; Jiang C; Liu Y; Lai L; Chen Q; Shen J; Wang Q
Int Immunopharmacol; 2012 Feb; 12(2):425-32. PubMed ID: 22226750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
